Yunyang Pharm

Yunyang Pharm most likely refers to Jiangsu Yunyang Group Pharmaceutical, a China-based pharmaceutical manufacturer located in Danyang, Jiangsu. The company appears to be an active producer of finished-dose generic medicines and small-molecule active pharmaceutical ingredients, with approved products and manufacturing scope spanning tablets, hard capsules, ophthalmic and nasal drops, syrups, oral solutions, tinctures, and topical preparations. Publicly available Chinese business-registry information indicates the company also conducts drug R&D and traditional Chinese medicine pre-processing and extraction, but the visible evidence points primarily to a commercial generics/manufacturing business rather than an innovation-driven clinical-stage biotech pipeline. Named APIs/products associated with the company include clotrimazole, propafenone hydrochloride, clonidine hydrochloride, propranolol hydrochloride, clozapine, meloxicam, atorvastatin calcium, miconazole nitrate, econazole nitrate, apixaban, levornidazole, eplerenone, rivaroxaban, ribavirin eye drops, and ketotifen fumarate tablets. Overall, this looks like a regional Chinese pharmaceutical company with commercial manufacturing capabilities rather than a venture-backed discovery biotech.